(Q42542398)

2 November 2017

Carbamazepine-induced pseudolymphoma with CD-30 positive cells (English)

1 reference

2 November 2017

1 reference

D L Nathan

1

1 reference

PubMed ID

9591791

2 November 2017

D V Belsito

series ordinal

2

1 reference

PubMed ID

9591791

2 November 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

2 November 2017

4

1 reference

Journal of the American Academy of Dermatology

inferred from page(s)

published in

1 reference

2 November 2017

38

1 reference

2 November 2017

5 Pt 2

1 reference

2 November 2017

806-809

1 reference

Carbamazepine hypersensitivity syndrome: report of 4 cases and review of the literature

2 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970463-3

7 January 2021

Pseudo-lymphoma associated with carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970463-3

7 January 2021

Carbamazepine-induced pseudolymphoma and immune dysregulation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970463-3

7 January 2021

Hypersensitivity to carbamazepine presenting as pseudolymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970463-3

7 January 2021

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 26-1996. A seven-year-old boy with fever, lymphadenopathy, hepatosplenomegaly, and prominent eosinophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970463-3

7 January 2021

Carbamazepine-induced anticonvulsant hypersensitivity syndrome--pathogenic and diagnostic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970463-3

7 January 2021

The anticonvulsant hypersensitivity syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970463-3

7 January 2021

Hypersensitivity to carbamazepine presenting with a leukemoid reaction, eosinophilia, erythroderma, and renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970463-3

7 January 2021

Anticonvulsant hypersensitivity syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970463-3

7 January 2021

Hydantoin-induced pseudo-pseudolymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970463-3

7 January 2021

10.1016/S0190-9622(98)70463-3

Identifiers

DOI

1 reference

2 November 2017

1 reference

PubMed ID

9591791